Recently, Teva (TEVA) launched a generic version of an oral contraceptive drug. The new drug is a generic version of Minastrin. The company’s generic drugs continue to build revenue year over year.
Teva has a chance to profit well with its generic version of the drug. Minastrin from Allergan generates a good amount of revenue.
Generic Version Minastrin
With the launch of the generic version of the drug, Minastrin, Teva increased its portfolio of contraceptive drugs. It brings the total amount of generic contraceptive drugs in its arsenal to over 50.
That puts the company as one of the main leaders in this space. Around 50% of the prescriptions in the United States for contraception come from Teva.
That is only the beginning for the big pharmaceutical giant. In the United States alone, it boasts at least 600 generic products. In other words, one in six prescriptions written in the U.S. for a generic product comes from Teva.
Competitor
Minastrin is sold by a big pharmaceutical company by the name of Allergan (AGN). The drug is a contraceptive drug that combines two hormones. It combines progestin and estrogen. Both these hormones make it difficult for a women to get pregnant.
This drug has done well for Allergan. That is because Allergan reported the product’s revenue in its most recent earnings report. In the fourth quarter of 2016 alone, Minastrin earned $78.4 million.
Total sales for the drug in all of 2016 reached around $361 million. Even if Teva reaches half that amount in sales, it will be a nice boost for the company. It seems as though it is in good shape when it comes to this new generic drug. The problem is that it is not always so easy. With the generic version of Minastrin going against the original it will have a tough uphill battle.
That is especially true considering the amount of side effects the generic version has. Such side effects include: increased cardiovascular risk for smokers, danger for those with hypertension, and also trouble for those who are pregnant. These side effects may inhibit sales in one way or another.
Leave A Comment